Recruiting

Observational StudyVolume Outcome Relationships and Effects

Sponsor:

Methodist Health System

Code:

NCT06343597

Conditions

Esophageal Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Study Details

Brief summary:

This is a retrospective analysis to assess if high-volume hospital facilities experience greater or lesser rates of incidence in patients with esophageal cancer than low-volume facilities.

Conditions

Esophageal Cancer

Study ID

NCT06343597

Start date

Jun 15, 2020

Status verified date

Jan, 2026

Completion date

Jun 15, 2028

Anticipated

Primary completion date

Jun 15, 2027

Anticipated

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

esophageal cancer

Exclusion Criteria:

No esophageal cancer

Study Design

Enrollment

30 participants

Anticipated

Interventions and Outcome Measures

Primary outcome measure

Esophageal Cancer resection in patients in high volume (more than 5 esophagectomy performed per year) and low volume (less than 5 esophagectomy performed per year) hospital facilities [ Time Frame: through study completion, up to 18 months ]

Central Contacts and Locations

Central contacts

Crystee Cooper, DHEd

214-947-1280 clinicalresearch@mhd.com

Zaid Haddadin, MS

214-947-1280 clinicalresearch@mhd.com

Locations

Methodist Richardson Medical Center

Recruiting

Richardson, Texas, United States, 75082

Contacts

Crystee Cooper, DHEd

2149471280 clinicalresearch@mhd.com

Zaid Haddadin, MS

2149471280 clinicalresearch@mhd.com

Principal Investigator:

Dhiresh Jeyarajah, MD

More Information

Sponsor

Methodist Health System

Last update posted

Mar 20, 2026

Last verified

Jan, 2026

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by Methodist Health System on 2026-03-20.